CEB8- A DECISION ANALYTIC MODEL MEASURING THE COST-EFFECTIVENESS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN HIV PATIENTS WITH HIGH VERSUS LOW BASELINE VIRAL LOAD- AN INDINAVIR PLUS LAMIVUDINE ANDZIDOVUDINE EXAMPLE
Abstract
Authors
NA Risebrough P Oh A Rachlis D McMurchy M Bast M Doswell